Teradyne price target raised to $387 from $376 at Morgan Stanley

Morgan Stanley analyst Shane Brett raised the firm’s price target on Teradyne (TER) to $387 from $376 and keeps an Equal Weight rating on the shares. Bull-case networking expectations will have to be tempered, but Morgan Stanley’s estimates come up, and the firm would be inclined to be incrementally more positive than negative, the analyst tells investors in a research note. The firm added that it still likes Teradyne’s underlying fundamentals, even if the recent earnings report fuels further debate around the networking blue-sky scenario.